Exact Mass: 306.0426

Exact Mass Matches: 306.0426

Found 65 metabolites which its exact mass value is equals to given mass value 306.0426, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoate

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid

C14H10O8 (306.0376)


2-(3,4-dihydroxybenzoyloxy)-4,6-dihydroxybenzoate is part of the Flavonoid metabolism pathway. It is a substrate for: Pirin.

   

Phenyl 5-phospho-alpha-D-ribofuranoside

phenyl 5-phosphono-alpha-D-ribofuranoside

C11H15O8P (306.0505)


   

4-(beta-D-Ribofuranosyl)phenol 5-phosphate

4-(beta-D-Ribofuranosyl)phenol 5-phosphate

C11H15O8P (306.0505)


   

Vadadustat

Vadadustat

C14H11ClN2O4 (306.0407)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials B - Blood and blood forming organs > B03 - Antianemic preparations C78275 - Agent Affecting Blood or Body Fluid C471 - Enzyme Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor[1]. Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo[1][2].

   

N-(4-Carboxy-4-Oxobutanoyl)-L-Cysteinylglycine

N-(4-Carboxy-4-Oxobutanoyl)-L-Cysteinylglycine

C10H14N2O7S (306.0522)


   

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphuric acid

C11H14O8S (306.0409)


4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate belongs to the family of Hydroxy Fatty Acids. These are fatty acids in which the chain bears an hydroxyl group.

   

4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid

4-Hydroxy-5-[4-hydroxy-3-(sulphooxy)phenyl]pentanoic acid

C11H14O8S (306.0409)


4-hydroxy-5-[4-hydroxy-3-(sulfooxy)phenyl]pentanoic acid is a predicted metabolite generated by BioTransformer¹ that is produced by the metabolism of 5-(3,4-dihydroxyphenyl)-4-hydroxypentanoic acid. It is generated by Sulfotransferase 1A3 (P0DMM9) and Sulfotransferase enzymes via a -3-O-sulfation-of-phenolic-compound reaction. This -3-O-sulfation-of-phenolic-compound occurs in humans.

   

4-Hydroxy-5-(3',4'-dihydroxyphenyl)-valeric acid 4'-sulfate

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulphuric acid

C11H14O8S (306.0409)


   

4-Hydroxy-5-(3',5'-dihydroxyphenyl)-valeric acid sulfate

4-Hydroxy-5-(3,5-dihydroxyphenyl)-valeric acid sulphuric acid

C11H14O8S (306.0409)


   

Dictyostelium

1-((3,5-Dichloro)-2,6-dihydroxy-4-methoxyphenyl)-1-hexanone

C13H16Cl2O4 (306.0426)


   

2-[(4-Phenoxyphenyl)sulfonylmethyl]thiirane

2-[(4-Phenoxybenzenesulphonyl)methyl]thiirane

C15H14O3S2 (306.0384)


   

Methyl brevifolin carboxylate

Methyl brevifolin carboxylate

C14H10O8 (306.0376)


   
   
   
   

Methyl brevifolincarboxylate

Methyl 7,8,9-trihydroxy-3,5-dioxo-1,2,3,5-tetrahydrobenzo[d]cyclopenta[b]pyran-1-carboxylate

C14H10O8 (306.0376)


Methyl brevifolincarboxylate is an organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity. It has a role as a metabolite, a vasodilator agent, an EC 5.99.1.2 (DNA topoisomerase) inhibitor, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, a radical scavenger and a platelet aggregation inhibitor. It is an organic heterotricyclic compound, a delta-lactone, a member of phenols and a cyclic ketone. Methyl brevifolincarboxylate is a natural product found in Euphorbia maculata and Phyllanthus niruri with data available. An organic heterotricyclic compound that is 1,2,3,5-tetrahydrocyclopenta[c]isochromene substituted by hydroxy groups at positions 7, 8 and 9, oxo groups at positions 3 and 5 and a methoxycarbonyl group at position 1. Isolated from Phyllanthus urinaria and Phyllanthus niruri, it exhibits vasorelaxant activity.

   
   
   

Phyllanthusiin E methyl ester

Phyllanthusiin E methyl ester

C14H10O8 (306.0376)


   

6-Deoxy,6beta-chloro-Cyathiformine B|cyathiformine C|cyathioformine C

6-Deoxy,6beta-chloro-Cyathiformine B|cyathiformine C|cyathioformine C

C12H15ClO7 (306.0506)


   
   

7-hydroxy-3-phenyl-2-(trifluoromethyl)chromen-4-one

7-hydroxy-3-phenyl-2-(trifluoromethyl)chromen-4-one

C16H9F3O3 (306.0504)


   

6-(2-Thienyl)-2-[3-(2-thienyl)-2-aziridinyl]-3-oxa-1-azabicyclo[3.1.0]

6-(2-Thienyl)-2-[3-(2-thienyl)-2-aziridinyl]-3-oxa-1-azabicyclo[3.1.0]

C14H14N2O2S2 (306.0497)


   

6-Bromo-2-cyclohexylquinazolin-4(3H)-one

6-Bromo-2-cyclohexylquinazolin-4(3H)-one

C14H15BrN2O (306.0368)


   

2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid compound with sulfuric acid (1:1)

2-Amino-4-(2-aminophenyl)-4-oxobutanoic acid compound with sulfuric acid (1:1)

C10H14N2O7S (306.0522)


   

L -Kynurenine sulfate salt

L -Kynurenine sulfate salt

C10H14N2O7S (306.0522)


   

Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate

Methyl [(4-chloro-3-cyano-7-methoxy-6-quinolinyl)oxy]acetate

C14H11ClN2O4 (306.0407)


   

4-(METHYLSULPHONYL)ANILINE

4-(METHYLSULPHONYL)ANILINE

C14H15BrN2O (306.0368)


   

1,2,11,12-Tetrachlorododecane

1,2,11,12-Tetrachlorododecane

C12H22Cl4 (306.0476)


   

2-(3-Bromophenyl)-5-cyclohexyl-1,3,4-oxadiazole

2-(3-Bromophenyl)-5-cyclohexyl-1,3,4-oxadiazole

C14H15BrN2O (306.0368)


   

l-kynurenine sulfate

l-kynurenine sulfate

C10H14N2O7S (306.0522)


   

4-BUTYL-4-BROMO-3-FLUOROBIPHENYL

4-BUTYL-4-BROMO-3-FLUOROBIPHENYL

C16H16BrF (306.0419)


   

2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate

2-Chloro-1,3-bis(dimethylamino)trimethinium hexafluorophosphate

C7H14ClF6N2P (306.0487)


   

Triphenylarsine

Triphenylarsine

C18H15As (306.039)


   

4-amino-2-[(2-chlorophenoxy)methyl]-6-methylsulfanylpyrimidine-5-carbonitrile

4-amino-2-[(2-chlorophenoxy)methyl]-6-methylsulfanylpyrimidine-5-carbonitrile

C13H11ClN4OS (306.0342)


   

N,N-Dimethyl-10H-phenothiazine-2-sulfonamide

N,N-Dimethyl-10H-phenothiazine-2-sulfonamide

C14H14N2O2S2 (306.0497)


   

2-[[3,5-bis(trifluoromethyl)phenyl]hydrazinylidene]propanedinitrile

2-[[3,5-bis(trifluoromethyl)phenyl]hydrazinylidene]propanedinitrile

C11H4F6N4 (306.034)


   

5-(3,3-DIMETHYL-UREIDO)-2-ETHOXY-BENZENESULFONYL CHLORIDE

5-(3,3-DIMETHYL-UREIDO)-2-ETHOXY-BENZENESULFONYL CHLORIDE

C11H15ClN2O4S (306.0441)


   

3-Ethyl-5-[3-ethyl-2(3H)-benzothiazolylidene]-2-thioxo-4-oxazolidinone

3-Ethyl-5-[3-ethyl-2(3H)-benzothiazolylidene]-2-thioxo-4-oxazolidinone

C14H14N2O2S2 (306.0497)


   

2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate

2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate

C7H14ClF6N2P (306.0487)


   

3-[(2-chloro-6-fluorophenyl)methyl]-7,8-dihydro-6H-chromene-2,5-dione

3-[(2-chloro-6-fluorophenyl)methyl]-7,8-dihydro-6H-chromene-2,5-dione

C16H12ClFO3 (306.0459)


   

3-(4-Bromophenyl)-5-cyclohexyl-1,2,4-oxadiazole

3-(4-Bromophenyl)-5-cyclohexyl-1,2,4-oxadiazole

C14H15BrN2O (306.0368)


   
   
   

1,1,1,3-Tetrachlorododecane

1,1,1,3-Tetrachlorododecane

C12H22Cl4 (306.0476)


   

7-HYDROXY-4-(3-TRIFLUOROMETHYLPHENYL)COUMARIN

7-HYDROXY-4-(3-TRIFLUOROMETHYLPHENYL)COUMARIN

C16H9F3O3 (306.0504)


   

6-Chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine

6-Chloro-2-(1-furo[2,3-c]pyridin-5-yl-ethylsulfanyl)-pyrimidin-4-ylamine

C13H11ClN4OS (306.0342)


   

2-[(4-Phenoxyphenyl)sulfonylmethyl]thiirane

2-[(4-Phenoxyphenyl)sulfonylmethyl]thiirane

C15H14O3S2 (306.0384)


   

5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid

5,5,6,6-Tetrahydroxybiphenyl-3,3-dicarboxylic acid

C14H10O8 (306.0376)


   
   

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate

4-Hydroxy-5-(3,4-dihydroxyphenyl)-valeric acid 4-sulfate

C11H14O8S (306.0409)


   

N-(6-chloro-1,3-benzothiazol-2-yl)-1,5-dimethyl-3-pyrazolecarboxamide

N-(6-chloro-1,3-benzothiazol-2-yl)-1,5-dimethyl-3-pyrazolecarboxamide

C13H11ClN4OS (306.0342)


   

2-[5-[2-[(4-Methylphenyl)thio]-1-oxoethyl]-2-thiophenyl]acetic acid

2-[5-[2-[(4-Methylphenyl)thio]-1-oxoethyl]-2-thiophenyl]acetic acid

C15H14O3S2 (306.0384)


   

(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine

(NZ)-N-(6-bromo-9-ethyl-3,4-dihydro-2H-carbazol-1-ylidene)hydroxylamine

C14H15BrN2O (306.0368)


   

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid

2-(3,4-Dihydroxybenzoyloxy)-4,6-dihydroxybenzoic acid

C14H10O8 (306.0376)


   

4-(5-O-phospho-beta-D-ribofuranosyl)phenol

4-(5-O-phospho-beta-D-ribofuranosyl)phenol

C11H15O8P (306.0505)


A ribose monophosphate that is D-ribofuranose 5-phosphate in which the anomeric OH group is replaced by a 4-hydroxy phenyl group (the beta-D-anomer).

   

phenyl 5-phosphono-alpha-D-ribofuranoside

phenyl 5-phosphono-alpha-D-ribofuranoside

C11H15O8P (306.0505)


   

1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one

1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one

C13H16Cl2O4 (306.0426)


A differentiation-inducing factor that is hexaphenone bearing two chloro substituents at positions 3 and 5, two hydroxy substituents at positions 2 and 6 as well as a single methoxy substituent at position 4. A secreted, chlorinated molecule that controls cell fate during development of Dictyostelium cells.

   

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate

4-Hydroxy-5-(dihydroxyphenyl)-valeric acid-O-sulphate

C11H14O8S (306.0409)


   

(z)-3',5,5',6'-tetrahydroxy-4,4'-dimethyl-[1,1'-bi(cyclohexylidene)]-3',4,5'-triene-2,2',3,6-tetrone

(z)-3',5,5',6'-tetrahydroxy-4,4'-dimethyl-[1,1'-bi(cyclohexylidene)]-3',4,5'-triene-2,2',3,6-tetrone

C14H10O8 (306.0376)


   

1,7,8-trihydroxy-3-methyl-10-oxo-1h-pyrano[4,3-b]chromene-9-carboxylic acid

1,7,8-trihydroxy-3-methyl-10-oxo-1h-pyrano[4,3-b]chromene-9-carboxylic acid

C14H10O8 (306.0376)


   

methyl 6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

methyl 6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

C12H15ClO7 (306.0506)


   

methyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate

methyl (1r)-7,8,9-trihydroxy-3,5-dioxo-1h,2h-cyclopenta[c]isochromene-1-carboxylate

C14H10O8 (306.0376)


   

methyl (3r,4r,5s,6s)-6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

methyl (3r,4r,5s,6s)-6-chloro-4,5-dihydroxy-3-[(3-methoxy-3-oxoprop-1-en-2-yl)oxy]cyclohex-1-ene-1-carboxylate

C12H15ClO7 (306.0506)


   

methyl 2-{11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraen-4-yl}acetate

methyl 2-{11,12-dihydroxy-3,8-dioxo-2,7-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(12),4,9(13),10-tetraen-4-yl}acetate

C14H10O8 (306.0376)